Orion Health Boosts Offering to UK's Largest Health Board

Orion HealthOrion Health (OHE:NZX/ASX) has significantly increased its offering to the United Kingdom's largest healthcare provider, the NHS Greater Glasgow and Clyde Health Board (NHS GGC), the company announced.

The publicly funded NHS GGC is one of the largest scale users of Orion Health technology with over 25,000 users. Located in west central Scotland, it delivers services through 35 hospitals, 10 specialised units, and 50 healthcare centres and clinics.

Orion Health has expanded its offering within the NHS GGC to deliver two new modules, Medicines Reconciliation and Problem List. In addition, the NHS GGC is extending its use of Orion Health's Coordinate solution by adopting Healthcare Pathways to support care coordination and patient transfer and handover.

Jonathan Selby, Orion Health Executive Vice President for Europe, Middle East and Africa, says the new solution will provide healthcare professionals with a comprehensive picture of an individual's care needs and help reduce the potential for any medication related errors.

"It will allow authorised users to understand a full list of patient allergies and problems, and enable them to keep track of medication changes that occur during an inpatient episode of care. After the patient is discharged from hospital it will provide a summary of these changes to other care professionals," Mr Selby says.

Colin Henderson, Orion Health Managing Director for the UK and Ireland adds "NHS GGC has acted as a beacon site for others and has driven forward the integrated health information agenda in Scotland, as well as acting as a reference study for health regions across the UK and internationally."

"We are delighted to be increasing our offering to NHS GGC, and look forward to continuing to work with the Board on enabling better healthcare delivery."

Related news articles:

About Orion Health
Orion Health (NZX:OHE) is a technology company that provides solutions which enable healthcare to over 90 million patients in more than 25 countries. Its open technology platform seamlessly integrates all forms of relevant data to enable population and personalised healthcare around the world. The company employs over 1200 people globally and is committed to continual innovation, investing over 30% of total operating revenue year to date in research and development, to cement its position at the forefront of Precision Medicine.

Most Popular Now

AI Predicts Lung Cancer Risk

An artificial intelligence (AI) program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a study published in the journal Radiology. Lung cancer is...

EU Health Policy Platform Calls for Prop…

The European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is...

What Next for Social Care?

Highland Marketing's advisory board welcomed Jane Brightman, social care lead at Institute of Health and Social Care Management, to discuss the sector and its technology needs. A lot of hope...

Philips Introduces the New Spectral Comp…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed...

Web-Based System Developed to Give Care …

Black Country Pathology Services has worked with CliniSys to create the ICE Portal, a web-based application that makes it easy for care homes, or other community care settings, to be...

Grand Challenge Research Harnesses AI to…

Breast cancer has recently overtaken lung cancer to become the most common cancer globally, according to the World Health Organization. Advancing the fight against breast cancer, the BreastPathQ Challenge was...

UCSF Improves Fetal Heart Defect Detecti…

UC San Francisco researchers have found a way to double doctors' accuracy in detecting the vast majority of complex fetal heart defects in utero - when interventions could either correct...

EU4Health Programme: Regulation (EU) 202…

The Programme should be a means of promoting actions in areas where there is a Union added value that can be demonstrated. Such actions should include, inter alia, strengthening...

MEDICA 2021 + COMPAMED 2021: Medical Tec…

15 - 18 November 2021, Düsseldorf, Germany. The date for the globally leading live platforms for the medical technology industry remains a fixed feature in everybody's calendar this year too. The...

New AI Technology Protects Privacy

Digital medicine is opening up entirely new possibilities. For example, it can detect tumors at an early stage. But the effectiveness of new AI algorithms depends on the quantity and...

GP use of Tech Helps Prevent Prescribing…

Academic analysis shows primary care prescribers have been preventing adverse drug reactions, harm and hospital admissions through safer prescribing, after using prescribing tech. The company behind the system also reveals...